News Focus
News Focus
icon url

XenaLives

10/11/17 3:14 PM

#124035 RE: falconer66a #124033

I think the point is that the "unexpected" results came from a small safety and dosage trial. We need a bigger trial to confirm.

I don't believe there is any other negative here. The company is moving forward in an orderly fashion.

icon url

frrol

10/11/17 3:27 PM

#124036 RE: falconer66a #124033

Then there's the investors. Folks who invest in a biotech's stock, stay on top of its clinical progress, keep an eye on the risks and potential, talk openly and objectively about them. There are a couple of investors here.
icon url

kevindenver

10/11/17 4:35 PM

#124046 RE: falconer66a #124033

A low sample size is a valid concern. Someone asked and I answered.

Nowhere do I state the results are "phony"..

BTW in case you don't know my alias I'm heavily long.
icon url

Steady_T

10/11/17 6:46 PM

#124060 RE: falconer66a #124033

Who will prove to have had it right from the start? The “No can tell, too small – stay out early” crowd? Or, the “Can’t be anything but good –- get in early” crowd



After the fact analysis is always 20/20. The question is how does one deal with the possibilities when there is insufficient information.

It's called risk management.

Some investors have invested only what they can afford to lose so that if 2-73 does not preform as expected in P2/3 their lifestyle will not be negatively affected.

Other investors see the potential rewards of 2-73 being so good that they are willing to risk more investment money and a failure will have some negative effects on their lifestyle or investing future.

Some investors here have said they have invested 100% in AVXL because they see the rewards as huge and the risk as very low at this point.

It's all about the risk-reward continuum and how much pain you are willing to accept if things go pear shaped.

Of course, if you are convinced that there is no possibility of failure then mortgaging the house is a reasonable choice.